Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:01 PM
Ignite Modification Date:
2025-12-24 @ 7:01 PM
NCT ID:
NCT03530657
Eligibility Criteria:
Inclusion Criteria:
* Patients undergoing a liver ultrasound exam due to confirmed Hepatitis B infection ,
* Patients having reached the age of majority in China,
* Patients with a liver biopsy for histological evaluation of liver fibrosis, performed within 3 months after the STE/STQ measurement date, and having the recommended quality criterion:
minimal length of biopsy samples of 15 mm, stored in paraffin minimal number of portal tracts of 6 per biopsy samples
* Patients of Chinese ethnic origin.
Exclusion Criteria:
Any of the conditions below will exclude patients from the study:
* Any patient presenting with combined etiologies of chronic liver diseases:，including Non hepatitis B viral infection（Hepatitis A, C, D, E）, alcoholic chronic liver disease, hemochromatosis, autoimmune hepatitis，etc
* Any patient presenting with a co-infection of HIV
* Any patient presenting with combined liver tumor
* Any patient ever received liver transplantation
* Pregnant women
* Acute hepatitis
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03530657
Study Brief:
Protocol Section:
NCT03530657